MARKET NEWS

Rafael Pharmaceuticals Announces Expansion Into France of Pivotal Phase 3 Trial
Bellerophon Receives Orphan Drug Designation
Wave Life Sciences Announces Fast Track Designation from US FDA
Ovid Therapeutics Announces First Patient Randomized in Pivotal Phase 3 Trial
Cellectar Presents Data From Phase 1 Study 
Allena Pharmaceuticals Completes Enrollment in Pivotal Phase 3 Trial
Oramed Announces Last Patient Treated in Pivotal Oral Insulin Trial

  FEATURED EDITORIAL

  COMPANY PROFILE

Pharmaceutical formulators continue to strive to create market leading products with maximum efficacy, quality, and performance. However, the inability to achieve API solubility and stability are common day-to-day challenges for formulators. With the help from Croda’s superior quality and ultrahigh purity specialty line of excipients, formulators are able to surpass these barriers, making Croda the supplier of choice in the global pharmaceutical market. Click here for more.

  EXCLUSIVE ONLINE CONTENT

2019 Analytical Testing in Drug Development eBook - Regulations Help Propel Testing Market

2019 Analytical Testing in Drug Development eBook - Regulations Help Propel Testing Market

This e-Book showcases the various types of services that leading testing companies offer and how they are helping industry comply with regulations to get their products approved and commercialized.

Accenture Announces Collaboration With Bayer

Accenture Announces Collaboration With Bayer

Accenture recently announced a collaboration with Bayer to implement the Accenture INTIENT Clinical platform to help simplify and speed its……

Sanofi & Abbott Partner, Changing the Way Diabetes is Managed

Sanofi & Abbott Partner, Changing the Way Diabetes is Managed

Sanofi and Abbott are partnering to integrate glucose sensing and insulin delivery technologies that would help to further simplify how people with diabetes……

AC Immune Receives Milestone Payment in Connection with Initiation of a Phase 2 Trial

AC Immune Receives Milestone Payment in Connection with Initiation of a Phase 2 Trial

AC Immune SA recently announced it has received a milestone payment from its partner Life Molecular Imaging in connection with the initiation of….

InveniAI Launches Suite of Products Powered by Artificial Intelligence Platform

InveniAI Launches Suite of Products Powered by Artificial Intelligence Platform

InveniAI Corporation recently announced the expansion of its flagship AI- and ML-driven innovation monitoring platform, AlphaMeld.  This expansion will provide…..

  DRUG DEVELOPMENT DIRECT RESOURCES

Upcoming eNewsletter Features:

October 2 – Gene Therapy
October 9 – API Synthesis